ATRANasdaq United States
Market cap
$76.136 M
$8.45 +2.42%
Close of 7 Aug 2026
Revenue
$120.8M
#2459 by revenue
Earnings
$32.7M
#1727 by earnings
Shares outstanding
8,178,114
Latest filing cover page
P/E ratio
2.3
Cap ÷ net income
Where these numbers come from
Share counts and financials for Atara Biotherapeutics are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.